Are You Choosing the Best Options to Reduce Persistent Cardiovascular Risk (P-CVR)?
Information provided by Amarin Pharma, Inc
1 in 3 Deaths in the US Are Due to Cardiovascular (CV) Disease
The staggering statistics around CV disease are increasing. CV disease is the leading cause of death in the US, even in the context of the devastating deaths associated with the COVID-19 pandemic. Approximately 92.1 million US adults live with some form of CV disease or the debilitating effects of stroke, but many have delayed routine preventative health visits over the past year. By 2035, the number of US adults living with CV disease is estimated to include nearly half of the US population, at approximately 131.2 million. Millions of patients take statins, which are the first step, along with diet and exercise, but statins don’t fully protect against persistent CV risk (P-CVR).
Visit truetoyourheart.com to learn more about why P-CVR remains the leading cause of death.
The Hard Truth About Fenofibrates
Your patients may be taking fenofibrates to lower their lipids. But you should know that fenofibrates, when used with statins, are not FDA-approved to reduce CV risk.
The FDA even withdrew approval for fenofibrates in combination with statins because the risk outweighed the benefit. That’s why the American Diabetes Association (ADA) stated that combining niacin and fenofibrates with statins is generally not recommended. In fact, niacin in combination with statins may increase the risk of stroke with additional side effects.
Let’s Get Real About Mixed Omega-3s
Millions of patients have turned to fish oil supplements to help lower CV risk. But here’s the catch: Fish oil supplements are not FDA-approved or intended to diagnose, treat, cure or prevent any disease. Seven clinical studies involving over 84,000 randomized patients have tried and failed to prove that prescription or supplement mixed-omega-3-containing products lower CV risk.
Many fish oil supplements aren’t entirely made up of omega-3s. And oftentimes you get lower amounts of omega-3s than what’s listed on the label. On average, fish oil supplements only contain 30% of the omega-3 fatty acids EPA and DHA. It’s important to note that certain ingredients could undo the beneficial effects of statin therapy. Fish oil supplements may contain up to 70% unknown impurities, saturated fats and various omega mixtures.
Disclaimer
The posting of sponsored information and content on this page should not be considered an AAFP endorsement or recommendation of the sponsor's products, services, policies, or procedures. The information and opinions expressed on this page are those of the paid sponsors and do not necessarily reflect the view of the AAFP. The AAFP is not responsible for the content of third-party websites linked from this page; moreover, any links on this page to third-party websites where goods or services are advertised are not endorsements or recommendations by the AAFP of the third-party sites, goods, or services.